PET imaging of neural activity, -amyloid, and tau in normal brain aging
Kai Zhang,Hiroshi Mizuma,Xiaohui Zhang,Kayo Takahashi,Chentao Jin,Fahuan Song,Yuanxue Gao,Yousuke Kanayama,Yuping Wu,Yuting Li,Lijuan Ma,Mei Tian,Hong Zhang,Yasuyoshi Watanabe
DOI: https://doi.org/10.1007/s00259-021-05230-5
2021-01-01
Abstract:Normal brain aging is commonly associated with neural activity alteration, beta-amyloid (A beta) deposition, and tau aggregation, driving a progressive cognitive decline in normal elderly individuals. Positron emission tomography (PET) with radiotracers targeting these age-related changes has been increasingly employed to clarify the sequence of their occurrence and the evolution of clinically cognitive deficits. Herein, we reviewed recent literature on PET-based imaging of normal human brain aging in terms of neural activity, A beta, and tau. Neural hypoactivity reflected by decreased glucose utilization with PET imaging has been predominately reported in the frontal, cingulate, and temporal lobes of the normal aging brain. A beta PET imaging uncovers the pathophysiological association of A beta deposition with cognitive aging, as well as the potential mechanisms. Tau-associated cognitive changes in normal aging are likely independent of but facilitated by A beta as indicated by tau and A beta PET imaging. Future longitudinal studies using multi-radiotracer PET imaging combined with other neuroimaging modalities, such as magnetic resonance imaging (MRI) morphometry, functional MRI, and magnetoencephalography, are essential to elucidate the neuropathological underpinnings and interactions in normal brain aging.